Practice Guideline Track on Hypertrophic Cardiomyopathies

Guidelines into Practice

Topic(s):

Cardiovascular Surgery

Myocardial Disease

Congenital Heart Disease and Pediatric Cardiology

Device Therapy

Treatment

Interventional Cardiology

Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Chronic Heart Failure

Epidemiology, Prognosis, Outcome

Contributor: Special thanks to Stefano Nistri from the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Based on the 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy.

Updated with ESC Congress 2015 sessions!

2014 ESC webinar on "How the new ESC Guidelines on cardiomyopathies will change my practice?" Watch the recording.

Session Title	Slides	Webcast
Guidelines in Practice
A hypertrophic cardiomyopathy patient with skeletal muscle weakness and visual impairment
A hypertrophic cardiomyopathy patient with skeletal muscle weakness and visual impairment - What do the Guidelines say?
A hypertrophic cardiomyopathy patient with skeletal muscle weakness and visual impairment - Conclusion and take home message
A hypertrophic cardiomyopathy patient with intermediate sudden cardiac death risk
A hypertrophic cardiomyopathy patient with intermediate sudden cardiac death risk - What do the Guidelines say?
A hypertrophic cardiomyopathy patient with intermediate sudden cardiac death risk. Conclusion and take home message
Multimodality / hybrid imaging, other imaging
Hypertrophic cardiomyopathy: Imaging guided management in recent ESC Guidelines
Hypertrophic cardiomyopathy - What do the Guidelines say? Imaging guided management in recent ESC Guidelines
Hypertrophic cardiomyopathy - Conclusion and take home message. Imaging guided management in recent ESC Guidelines

Session Title	Slides	Webcast
ESC Guidelines 2014 overview: Hypertrophic Cardiomyopathy
ESC Guidelines: a systematic approach to the diagnosis of hypertrophic cardiomyopathy
ESC Guidelines: guidelines for genetic testing in hypertrophic cardiomyopathy
ESC Guidelines: recommended approach to the assessment and treatment of symptoms
ESC Guidelines: new guidelines on sudden death prevention
Myocardial disease in the 2014 ESC Guidelines on hypertrophic cardiomyopathy: what do the Guidelines say
Meet the Guidelines Task Force II

Topics	Session Title	Slides	Webcast
Prognosis in hypertrophic cardiomyopathy	A new risk stratification algorythm for sudden cardiac death
	Is there a role for biomarkers
	Atrial fibrillation and stroke prevention
The challenge of pregnancy in grown-up congenital heart disease and cardiomyopathy	Pregnancy and heart disease
Diagnostic challenges in cardiomyopathies	Genetic diagnosis should always be considered for cardiomyopathy. PRO
Diagnostic challenges in cardiomyopathies	Genetic diagnosis should always be considered for cardiomyopathy. CONTRA